Effect of Race and Sex on Single and Multiple Dose Pharmacokinetics of Desloratadine

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2165/00003088-200241001-00004PMID 12169043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Bioavailability of Desloratadine Is Unaffected by Food

  2002cited by this paper
• A Pharmacokinetic Profile of Desloratadine in Healthy Adults, Including Elderly

  2002cited by this paper
• Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis

  2001cited by this paper
• Gender differences in pharmacokinetics and pharmacodynamics.

  1999cited by this paper
• Influence of gender on the pharmacokinetics and pharmacodynamics of drugs.

  1998cited by this paper
• Influence of race or ethnicity on pharmacokinetics of drugs.

  1997cited by this paper
• Gender differences in pharmacokinetics

  1996cited by this paper
• Gender Effects in Pharmacokinetics and Pharmacodynamics

  1995cited by this paper
• Ethnic Differences in Drug Disposition and Responsiveness

  1991cited by this paper

• Simultaneously Predicting Pharmacokinetics of Loratadine and Desloratadine in Children Using a Whole‐Body Physiologically Based Pharmacokinetic Model

  2024cites this paper
• Comparison of the Pharmacokinetics of Generic Versus Branded Obeticholic Acid in a Chinese Population: Effects of Food and Sex

  2021cites this paper
• A randomized study on the bioequivalence of desloratadine in Chinese healthy subjects and the association of different metabolic phenotypes with UGT2B10 and CYP2C8 genotypes.

  2020cites this paper
• Structural and clinical impact of anti-allergy agents: An overview.

  2019cites this paper
• Sex differences in the pharmacology of itch therapies-a narrative review.

  2019cites this paper
• Association between desloratadine and prednisolone in the treatment of children with acute symptoms of allergic rhinitis: a double-blind, randomized and controlled clinical trial

  2016cites this paper
• Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers

  2015cites this paper
• Safety evaluation of desloratadine in allergic rhinitis

  2013cites this paper
• Second-Generation Antihistamines

  2012cites this paper
• Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males

  2012cites this paper
• Desloratadine

  2012cites this paper
• Antihistamines (H1 receptor antagonists)

  2010cites this paper
• From pharmacokinetics to therapeutics

  2009cites this paper
• Pharmacokinetics in special populations

  2009influential citation
• Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine

  2008cites this paper
• Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

  2006cites this paper
• Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.

  2006cites this paper
• Cardiotoxicité des antihistaminiques de deuxième génération

  2006cites this paper
• Revue générale Cardiotoxicité des antihistaminiques de deuxième génération ☆ Cardiotoxicity of second generation antihistamines

  2006cites this paper
• Desloratadine for allergic rhinitis

  2006cites this paper
• Combining desloratadine and pseudoephedrine in the treatment of seasonal allergic rhinitis

  2006cites this paper
• The Safety and Efficacy of Desloratadine for the Management of Allergic Disease

  2005cites this paper
• Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines

  2005cites this paper
• Antihistamines (H 1 receptor antagonists)

  2005cites this paper
• Disposition of desloratadine in healthy volunteers

  2005cites this paper
• Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders

  2005cites this paper
• Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans

  2004cites this paper
• Pharmacokinetics and Bioequivalence Study of a Generic Desloratadine Tablet Formulation in Healthy Male Volunteers

  2004cites this paper
• A Pharmacokinetic Profile of Desloratadine in Healthy Adults, Including Elderly

  2002cites this paper
• Desloratadine Has No Clinically Relevant Electrocardiographic or Pharmacodynamic Interactions with Ketoconazole

  2002cites this paper
• Desloratadine: A new, nonsedating, oral antihistamine.

  2001cites this paper